![Fabio Chianelli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fabio Chianelli
Amministratore Delegato presso PHARMATHER HOLDINGS LTD.
Patrimonio netto: 3 M $ in data 31/05/2024
Posizioni attive di Fabio Chianelli
Società | Posizione | Inizio | Fine |
---|---|---|---|
PHARMATHER HOLDINGS LTD. | Amministratore Delegato | 01/01/2020 | - |
Presidente | 01/01/2020 | - | |
DIAGNAMED HOLDINGS CORP. | Presidente | - | - |
Amministratore Delegato | 11/08/2021 | - | |
Direttore/Membro del Consiglio | 11/08/2021 | - | |
Presidente | 11/08/2021 | - | |
Fabiotech, Inc.
![]() Fabiotech, Inc. Advertising/Marketing ServicesCommercial Services Fabiotech, Inc. provides outdoor advertising services. The private company is based in Woodbridge, Canada and was founded in 2004. | Corporate Officer/Principal | - | - |
Revive Therapeutics, Inc.
![]() Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Fondatore | - | - |
Presidente | - | - | |
Pharmather, Inc.
![]() Pharmather, Inc. Pharmaceuticals: MajorHealth Technology Pharmather, Inc. operates as a pharmaceutical company. The firm focuses on drug repurposing with artificial intelligence. The company is headquartered in Toronto, Canada. | Amministratore Delegato | - | - |
Storia della carriera di Fabio Chianelli
Precedenti posizioni note di Fabio Chianelli
Società | Posizione | Inizio | Fine |
---|---|---|---|
REVIVE THERAPEUTICS LTD. | Direttore/Membro del Consiglio | 27/03/2012 | 18/12/2019 |
Amministratore Delegato | 27/03/2012 | 05/07/2016 | |
Fondatore | 27/03/2012 | 18/12/2019 | |
Presidente | 05/07/2016 | 18/12/2019 | |
TITAN MEDICAL INC. | Contatto Relazioni con gli Investitori | - | - |
Public Communications Contact | - | - | |
Consigliere Generale | - | - |
Formazione di Fabio Chianelli
Toronto Metropolitan University of | Undergraduate Degree |
Statistiche
Distribuzione geografica
Canada | 9 |
Posizioni
Chief Executive Officer | 4 |
President | 3 |
Director/Board Member | 2 |
Settori
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
TITAN MEDICAL INC. | Health Technology |
REVIVE THERAPEUTICS LTD. | Health Technology |
PHARMATHER HOLDINGS LTD. | Health Technology |
DIAGNAMED HOLDINGS CORP. | Health Technology |
Aziende private | 3 |
---|---|
Revive Therapeutics, Inc.
![]() Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Health Technology |
Fabiotech, Inc.
![]() Fabiotech, Inc. Advertising/Marketing ServicesCommercial Services Fabiotech, Inc. provides outdoor advertising services. The private company is based in Woodbridge, Canada and was founded in 2004. | Commercial Services |
Pharmather, Inc.
![]() Pharmather, Inc. Pharmaceuticals: MajorHealth Technology Pharmather, Inc. operates as a pharmaceutical company. The firm focuses on drug repurposing with artificial intelligence. The company is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Fabio Chianelli
- Esperienza